Search research articles
Contact Us
Filters
Showing results (121-130 of 186) with videos related to
Page
of 19
Sort By:
British Journal of Obstetrics and Gynaecology
|
May 1, 1978
Serum FSH, LH and oestrone levels in postmenopausal patients on oestrogen therapy
U Larsson-Cohn, E D Johansson, B Kågedal, et al.
Acta Obstetricia Et Gynecologica Scandinavica
|
January 1, 1986
Effects on the lipoprotein metabolism of an antiandrogen-estrogen oral contraceptive drug
U Larsson-Cohn, L Fåhraeus, H von Schenck, et al.
The American Journal of Cardiology
|
September 20, 1997
Noninvasive risk stratification in unstable coronary artery disease: exercise test and biochemical markers. FRISC Study Group
B Lindahl, B Andrén, J Ohlsson, et al.
American Heart Journal
|
February 1, 1992
The predictive value of silent ischemia at an exercise test before discharge after an episode of unstable coronary artery disease. RISC Study Group
I Nyman, H Larsson, M Areskog, et al.
International Journal of Cardiac Imaging
|
June 1, 1995
Additional value of thallium-201 SPECT to a conventional exercise test for the identification of severe coronary lesions after an episode of unstable coronary artery disease
J E Karlsson, A Björkholm, E Nylander, et al.
International Journal of Cardiology
|
May 1, 1993
Risk stratification by early exercise testing after an episode of unstable coronary artery disease. The RISC Study Group
I Nyman, L Wallentin, M Areskog, et al.
Journal of Internal Medicine
|
September 1, 1993
Very early risk stratification by electrocardiogram at rest in men with suspected unstable coronary heart disease. The RISC Study Group
I Nyman, M Areskog, N H Areskog, et al.
Thrombosis and Haemostasis
|
March 12, 2011
The PLATO trial reveals further opportunities to improve outcomes in patients with acute coronary syndrome. Editorial on Serebruany. "Viewpoint: Paradoxical excess mortality in the PLATO trial should be independently verified" (Thromb Haemost 2011; 105.5)
L Wallentin, R C Becker, S K James, et al.
Der Urologe. Ausg. A
|
July 1, 1981
[Effects of cyproterone acetate on cardiovascular risk factors in patients with carcinoma of the prostate (author's transl)]
E Varenhorst, B E Karlberg, B Risberg, et al.
Cardiology
|
August 31, 2000
Prognostic value of ischemia monitoring with on-line vectorcardiography in patients with unstable coronary artery disease
P Lundin, J Jensen, B Lindahl, et al.
Page
of 19
Search research articles
Search
Showing results (121-130 of 186) with videos related to
Sort By:
Page
of 19
British Journal of Obstetrics and Gynaecology
|
May 1, 1978
Serum FSH, LH and oestrone levels in postmenopausal patients on oestrogen therapy
U Larsson-Cohn, E D Johansson, B Kågedal, et al.
Acta Obstetricia Et Gynecologica Scandinavica
|
January 1, 1986
Effects on the lipoprotein metabolism of an antiandrogen-estrogen oral contraceptive drug
U Larsson-Cohn, L Fåhraeus, H von Schenck, et al.
The American Journal of Cardiology
|
September 20, 1997
Noninvasive risk stratification in unstable coronary artery disease: exercise test and biochemical markers. FRISC Study Group
B Lindahl, B Andrén, J Ohlsson, et al.
American Heart Journal
|
February 1, 1992
The predictive value of silent ischemia at an exercise test before discharge after an episode of unstable coronary artery disease. RISC Study Group
I Nyman, H Larsson, M Areskog, et al.
International Journal of Cardiac Imaging
|
June 1, 1995
Additional value of thallium-201 SPECT to a conventional exercise test for the identification of severe coronary lesions after an episode of unstable coronary artery disease
J E Karlsson, A Björkholm, E Nylander, et al.
International Journal of Cardiology
|
May 1, 1993
Risk stratification by early exercise testing after an episode of unstable coronary artery disease. The RISC Study Group
I Nyman, L Wallentin, M Areskog, et al.
Journal of Internal Medicine
|
September 1, 1993
Very early risk stratification by electrocardiogram at rest in men with suspected unstable coronary heart disease. The RISC Study Group
I Nyman, M Areskog, N H Areskog, et al.
Thrombosis and Haemostasis
|
March 12, 2011
The PLATO trial reveals further opportunities to improve outcomes in patients with acute coronary syndrome. Editorial on Serebruany. "Viewpoint: Paradoxical excess mortality in the PLATO trial should be independently verified" (Thromb Haemost 2011; 105.5)
L Wallentin, R C Becker, S K James, et al.
Der Urologe. Ausg. A
|
July 1, 1981
[Effects of cyproterone acetate on cardiovascular risk factors in patients with carcinoma of the prostate (author's transl)]
E Varenhorst, B E Karlberg, B Risberg, et al.
Cardiology
|
August 31, 2000
Prognostic value of ischemia monitoring with on-line vectorcardiography in patients with unstable coronary artery disease
P Lundin, J Jensen, B Lindahl, et al.
Page
of 19